Document is current
Any future updates will be listed below
-
Authors
Mahendran, Malena
Upton, Julia E. M.
Ramasubramanian, Ramya
Memmott, Heidi L.
Germain, Guillaume
Büsch, Katharina
Laliberté, François
Harrington, Amanda
-
Funding
Funding for this research was provided by:
Pharming Healthcare, Inc (Pharming Healthcare, Inc)
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 15 April 2025
First Online: 3 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: AH and HLM are employees of Pharming Healthcare, Inc. JEMU reports consulting for and steering committee membership with Pharming Healthcare, Inc, both outside of the current work, advising fees from Pfizer and Bausch Health, speaker fees from AstraZeneca, clinical trial funding (to institution) from Regeneron and Sanofi, and drug donation for clinical trial use from Novartis. KB is an employee of KJM Büsch Consulting GmbH. MM, RR, GG, and FL are employees of Groupe d’analyse, Ltée, a consulting company that received research funding from Pharming Healthcare, Inc, to conduct this study.
